| scholarly article | Q13442814 |
| P50 | author | Dirk Spitzer | Q59695111 |
| David T. Curiel | Q64384545 | ||
| P2093 | author name string | David G Mutch | |
| Matthew A Powell | |||
| Elena A Kashentseva | |||
| Igor P Dmitriev | |||
| William G Hawkins | |||
| Xingjian Jin | |||
| Allan B Dietz | |||
| Lindsay M Kuroki | |||
| P2860 | cites work | Identification of c-MYC as a target of the APC pathway | Q24310637 |
| Identification and characterization of a new member of the TNF family that induces apoptosis | Q24318423 | ||
| Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene | Q64379934 | ||
| The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12 | Q64383973 | ||
| Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand | Q73766150 | ||
| ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement | Q75270684 | ||
| Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma | Q39910399 | ||
| Cancer gene therapy using a novel secretable trimeric TRAIL. | Q40367155 | ||
| Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7. | Q40434351 | ||
| The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures | Q40992568 | ||
| Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. | Q41237683 | ||
| A multifunctional vector family for gene expression in mammalian cells | Q41428546 | ||
| Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency | Q44134997 | ||
| Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. | Q44486695 | ||
| Approaches to utilize mesenchymal progenitor cells as cellular vehicles | Q44495575 | ||
| Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isolated human pancreatic islets | Q44514969 | ||
| Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells | Q45859186 | ||
| Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro. | Q45872922 | ||
| Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK. | Q45883468 | ||
| Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer | Q45890453 | ||
| Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes | Q47761769 | ||
| Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. | Q51343855 | ||
| Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. | Q53288262 | ||
| Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family | Q24320301 | ||
| Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors | Q24673454 | ||
| Role of nanotechnology and gene delivery systems in TRAIL-based therapies | Q28076798 | ||
| Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain | Q28201285 | ||
| Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature | Q30010227 | ||
| TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population | Q33743051 | ||
| Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma | Q33834736 | ||
| Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma | Q34480527 | ||
| Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. | Q34490270 | ||
| Apo2L/TRAIL and its death and decoy receptors | Q34532325 | ||
| An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer | Q34577155 | ||
| Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. | Q35870225 | ||
| Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems | Q36089997 | ||
| Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ | Q36310187 | ||
| Cell-binding domain of adenovirus serotype 2 fiber | Q36634645 | ||
| Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology | Q36645343 | ||
| Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects | Q37073589 | ||
| Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy | Q37140126 | ||
| TRAIL gene therapy: from preclinical development to clinical application | Q37307340 | ||
| Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model | Q37310677 | ||
| Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane | Q37327815 | ||
| Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3. | Q37520449 | ||
| Applying synthetic lethality for the selective targeting of cancer. | Q38263612 | ||
| Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells | Q38461631 | ||
| Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology. | Q38557486 | ||
| Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy | Q39245228 | ||
| TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells | Q39319003 | ||
| Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy | Q39325378 | ||
| A genetically encoded multifunctional TRAIL trimer facilitates cell-specific targeting and tumor cell killing. | Q39689324 | ||
| Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. | Q39840843 | ||
| Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. | Q39852557 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| Adenoviridae | Q193447 | ||
| P304 | page(s) | e0190125 | |
| P577 | publication date | 2017-12-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer | |
| P478 | volume | 12 |
| Q58724855 | Concise Review: Neural Stem Cell-Mediated Targeted Cancer Therapies |
| Q61445684 | Streamlined procedure for gene knockouts using all-in-one adenoviral CRISPR-Cas9 |
| Q92987959 | Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer |
| Q99576115 | Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer |
Search more.